Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-16

FDA Approved: FEXOFENADINE HCL — Original Application (AKRON PHARMA INC)

View source ↗

Summary

FDA approved Akron Pharma Inc's original ANDA for fexofenadine hydrochloride (Fexofenadine HCl), a generic antihistamine for allergic rhinitis and urticaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexofenadine HCl (fexofenadine hydrochloride)

Snippet

ORIG AP for FEXOFENADINE HCL (FEXOFENADINE HCL)